Publications by authors named "Brian Lieberman"

Claim this Profile
C
Characterization of Sigma-2 Receptor-Specific Binding Sites Using [H]DTG and [I]RHM-4.
Chi-Chang Weng, Aladdin Riad, Brian P Lieberman, Kuiying Xu, Xin Peng

Pharmaceuticals (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoamine oxidase binding not expected to significantly affect [F]flortaucipir PET interpretation.
Justin P Wright, Jason R Goodman, Yin-Guo Lin, Brian P Lieberman, Jennifer Clemens

Eur J Nucl Med Mol Imaging· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alanine and glycine conjugates of (2S,4R)-4-[F]fluoroglutamine for tumor imaging.
Zhihao Zha, Karl Ploessl, Brian P Lieberman, Limin Wang, Hank F Kung

Nucl Med Biol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial infection imaging with [F]fluoropropyl-trimethoprim.
Mark A Sellmyer, Iljung Lee, Catherine Hou, Chi-Chang Weng, Shihong Li, Brian P Lieberman

Proc Natl Acad Sci U S A· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F](2,4)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition.
Rong Zhou, Austin R Pantel, Shihong Li, Brian P Lieberman, Karl Ploessl

Cancer Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative PET Reporter Gene Imaging with [C]Trimethoprim.
Mark A Sellmyer, Iljung Lee, Catherine Hou, Brian P Lieberman, Chenbo Zeng

Mol Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iodinated benzimidazole PARP radiotracer for evaluating PARP1/2 expression in vitro and in vivo.
Redmond-Craig Anderson, Mehran Makvandi, Kuiying Xu, Brian P Lieberman, Chenbo Zeng

Nucl Med Biol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of 4 and 6-carbon spacer conformationally flexible tetrahydroisoquinolinyl benzamide analogues for imaging the sigma-2 receptor status of solid tumors.
Iljung Lee, Brian P Lieberman, Shihong Li, Catherine Hou, Mehran Makvandi

Nucl Med Biol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic exploration of the effects of flexibility and basicity on sigma (σ) receptor binding in a series of substituted diamines.
Trent Conroy, Madhura Manohar, Yu Gong, Shane M Wilkinson, Michael Webster, Brian P Lieberman

Org Biomol Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy.
Mehran Makvandi, Kuiying Xu, Brian P Lieberman, Redmond-Craig Anderson, Samuel Sander Effron

Cancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer.
Christine E Edmonds, Mehran Makvandi, Brian P Lieberman, Kuiying Xu, Chenbo Zeng

Am J Nucl Med Mol Imaging· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pre-clinical characterization of an alpha-emitting sigma-2 receptor targeted radiotherapeutic.
Mehran Makvandi, Brian P Lieberman, Ben LeGeyt, Catherine Hou, David A Mankoff

Nucl Med Biol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer.
Mehran Makvandi, Estifanos D Tilahun, Brian P Lieberman, Redmond-Craig Anderson, Chenbo Zeng

Biochem Biophys Res Commun· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of tetrahydroindazole derivatives as sigma-2 receptor ligands.
Zong-Wen Wu, Shu-Yong Song, Li Li, He-Lin Lu, Brian Lieberman

Bioorg Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.
Zehui Wu, Zhihao Zha, Genxun Li, Brian P Lieberman, Seok Rye Choi

Mol Pharm· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.
Limin Wang, Brian P Lieberman, Karl Ploessl, Hank F Kung

Nucl Med Biol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.
Laetitia Lemoine, Brian P Lieberman, Karl Ploessl, Pinguan Zheng, Hank F Kung

Nucl Med Biol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol.
Pinguan Zheng, Brian P Lieberman, Karl Ploessl, Laetitia Lemoine, Sara Miller

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents.
Limin Wang, Zhihao Zha, Wenchao Qu, Hongwen Qiao, Brian P Lieberman

Nucl Med Biol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of VMAT2 binding sites in the brain by (18)F-AV-133: the effect of a pseudo-carrier.
Lin Zhu, Hongwen Qiao, Brian P Lieberman, Jingxiao Wu, Yajing Liu

Nucl Med Biol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.
Karl Ploessl, Limin Wang, Brian P Lieberman, Wenchao Qu, Hank F Kung

J Nucl Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Function of ovarian tissue after long-term storage.
Brian Lieberman

Reprod Biomed Online· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of novel tropane derivatives as potential PET imaging agents for the dopamine transporter.
Hongwen Qiao, Lin Zhu, Brian P Lieberman, Zhihao Zha, Karl Plössl

Bioorg Med Chem Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors.
Wenchao Qu, Shunichi Oya, Brian P Lieberman, Karl Ploessl, Limin Wang

J Nucl Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
Brian P Lieberman, Karl Ploessl, Limin Wang, Wenchao Qu, Zhihao Zha

J Nucl Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis